RX Drugnews homepage

  • Terms of Use


    Please read this User Agreement (amended as of May 19, 2007) before using this Service. By using this Service, you agree to be bound by all of the terms of this Agreement. The Service reserves the right to change the terms of this Agreement or to modify any components of this Service at any time.

    By continuing to use this site, you represent that you have read and agree to abide by the Agreement.

    Reproduction/Use of Material
    RxDrug News.com has been uniquely designed for presentation of content in a format specific to its users and with an integrity that we wish to maintain. Any unauthorized copy, reproduction, distribution, publication, display, modification, or transmission of any part of this Service is strictly prohibited. Users may download material from this Service for personal use. Without limiting the generality of the foregoing, you may not distribute any part of this Service over any network, nor sell or offer it for sale.

    See our Permissions section for more information on distribution. In addition, these files may not be used to construct any kind of database.

    Disclaimer: Limited Liability
    This Service is available "as is." without warranty, express or implied. The Sites are not warranted to be error free and we reserve the right to correct any errors or omissions in this Service. The Service makes no representations or warranties regarding the accuracy, reliability, currentness, completeness, or timeliness of the Content, software, text, graphics, videos, links, or communications provided on or through the use of the RxDrug News.com, goddady.com (hosting provider) websites or other related publications.

    In no event shall RxDrug News.com, its affiliates, its information providers, its licensors, its suppliers, or any third parties mentioned on any RxDrug News.com affiliated site be liable for any damages (including, without limitation, direct, indirect, incidental, special, consequential or punitive damages, personal injury/wrongful death, lost profits, or damages resulting from lost data or business interruption) resulting from the use of or inability to use the Sites or the Content, whether based on warranty, contract, tort, or any other legal theory, and whether or not RxDrug News.com, its affiliates, its licensors, its suppliers, or any third parties mentioned on the Sites are advised of the possibility of such damages. RxDrug News.com, its affiliates, its employees, its information providers, its licensors, its suppliers, or any third parties mentioned on the RxDrug News.com or goddady.com are not liable for any personal injury, including death, caused by your use or misuse of any of these Sites or content. Any claims arising in connection with your use of the Site or any content, must be brought within one (1) year of the date of the event giving rise to such action occurred. Remedies under these Terms and Conditions are exclusive and are limited to those expressly provided for in these Terms and Conditions.

    The Content of these Sites is for the sole purpose of being informative. The Content is not and should not be used or relied upon as medical, legal, financial or other advice. Nothing contained in RxDrug News.com websites or linked to by RxDrug News.com is intended by RxDrug News.com or its employees, affiliates or information providers to be instructional for medical diagnosis or treatment. It should not be used in place of a visit, call, consultation or the advice of your physician or other qualified health care provider. Always seek the advice of your physician or other qualified health care provider promptly if you have any healthcare-related questions or before you undergo any treatment or began a diet or fitness program. You should never disregard medical advice or delay in seeking it because of something you have read on RxDrug News.com or an affiliated Site.

    RxDrug News.com makes no representation regarding the satisfaction of any government regulations requiring disclosure of information on prescription drug products or the compliance or approval of any software with regard to the content contained on the Sites. Before trading stock users are advised to consult with a professional broker or other financial representative to verify information presented on the Sites. RxDrug News.com, its affiliates, employees, and information providers shall have no liability for investment decisions based on the information provided.

    With respect to any service, information, or goods that are available or advertised or sold through this Service, RxDrug News.com makes no warranties, express or implied, regarding the merchantability and/or fitness for a particular purpose.

    The Sites take reasonable preventative measures against viruses, worms and other destructive computer/internet spread destructive materials, but the Sites do not guarantee or warranty that any material downloaded from its Sites do not contain such destructive features. We are not liable for any damages stemming from such internet related dangers. If you use this Service or any of its materials, you do so solely at your own risk.

    Under no circumstances will RxDrug News.com or its affiliates or employees be liable for any direct, indirect, incidental, special, or consequential loss or damage arising from the use of or inability to use the Sites . It is the responsibility of the user to evaluate the accuracy, completeness or usefulness of any information, procedure, advice, opinion or other content available through RxDrug News.com, RxDrug News.com. Please secure the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content presented.

    The section headings used herein are for convenience only and shall not be given any legal import.

    Outgoing Links, Advertisers, Search Results
    The Sites may provide links to third-party web sites. These sites also may select certain sites as priority responses to search terms you enter and we may agree to allow advertisers to respond to certain search terms with advertisements or sponsored content. RxDrug News.com and its affiliates do not recommend and do not endorse the content on any third-party websites. RxDrug News.com and affiliates are not responsible for the content of linked third-party sites, third-party sites provided as search results, or third-party advertisements, and does not make any representations regarding their content or accuracy. Outgoing links may lead to sites that contain inaccurate information, false or misleading advertising, or information that violates copyright, libel or defamation laws. RxDrug News.com, affiliates and content providers make no representations concerning any effort to review all of the content of sites listed in outgoing links. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

    RxDrug News.com and its affiliates do not endorse any product advertised on the Sites.

    RSS Terms of Use
    Through its RSS (really simple syndication) service, RxDrug News.com offers feeds of story headlines and brief summaries in XML format ("RSS Content") to its users with RSS aggregators. The use of the RSS service is subject to this User Agreement. The Terms of Use, may be changed by RxDrug News.com at any time without notice. If you do not agree to all of the terms, do not use this Site’s RSS Feed.

    Use of RSS Feeds
    RxDrug News.com encourages the use of the RSS feeds to augment content on your own site or blog, provided that you do not publish the full text of our stories. You must use the RSS feeds as provided by RxDrug News.com, and you may not edit or modify the text, content or links supplied by RxDrug News.com. Any alteration of content or failure to display content will constitute a violation of these Terms of Use. You must also provide proper attribution (included in each RSS feed) by listing “RxDrug News.com” in text as the source for each article. RxDrug News.com reserves all rights in and to any RxDrug News.com logos, trademarks or trade names contained in any RSS feed, and your right to use these RxDrug News.com logos, trademarks or trade names is limited to providing attribution in connection with these RSS feeds. Any other uses, including without limitation the incorporation of advertising or other promotional content into, or the placement of advertising associated with or targeted towards the RSS Content, are strictly prohibited. You agree not to associate any RxDrug News.com RSS feeds with any content that might harm the reputation of RxDrug News.com, its affiliated sites, authors, employees, contributors or partners. Without limiting the above, you may not use the feed on any site that displays pornographic material, exploits children, provides instruction on or promotes illegal activities, or is in any way misleading, obscene, defamatory, libelous, or invasive of personal privacy.

    RxDrug News.com assumes no liability for the accuracy of the information in the feed, your activities in connection with the RSS feeds, or for any consequences resulting from your use of the information therein.

    You may not transfer these rights to any other party, nor may you act or warrant that you act on behalf of or as an agent of RxDrug News.com or its affiliated Sites.

    No Fees Permitted
    The feeds are free of charge for use by individuals and by organizations for commercial and non-commercial use. Users of RxDrug News.com’s RSS feeds content cannot charge additional fees or licenses for the RSS feed content.

    Attribution/Link to RxDrug News.com
    You agree to use the RSS Service only to provide headlines and summaries as provided by RxDrug News.com, each with a functional link to the full story on the RxDrug News.com website that shall display the full content immediately. You further agree not to frame or otherwise control the browser window (if any) in which our content opens, including limiting the size or position of such window, or to insert any interstitial pages, or other content between the RSS link and the web page.

    All RSS Feeds are protected by the copyright laws of the United States and international copyright treaties. All ownership rights and intellectual property rights in and to the RSS Feeds shall remain with RxDrug News.com and no part thereof shall be deemed assigned or licensed to you.

    Storing RxDrug News.com Materials
    You agree not to copy, duplicate or store any data retrieved from or derived from a RxDrug News.com feed beyond the normal amount provided by RxDrug News.com (approximately 40 headlines and summaries).

    Without limiting the above, no RxDrug News.com content may be entered into a database or other organizational structure without the prior written consent of RxDrug News.com.

    Right to Discontinue Feeds
    RxDrug News.com may modify or remove the list of available RSS feeds (or the content in the feeds) at any time without notifying you. Additionally, RxDrug News.com reserves the right to revoke RSS syndication privileges at any time, for any reason or for no reason.

    You agree to defend, indemnify, and hold RxDrug News.com , its officers, directors, employees, agents, licensors, information providers and suppliers, harmless from and against any claims, actions or demands, liabilities and settlements including without limitation, reasonable legal and accounting fees, resulting from, or alleged to result from, your use or inability to use

    RxDrug News.com or its affiliated websites, and also if you violate these Terms and Conditions.

    Copyright Policy
    RxDrug News.com Content is protected by copyright under both United States and foreign laws both by RxDrug News.com and content providers. Title to the Content of RxDrug News.com and affiliated websites, including goddady.com (hosting provider) remains with RxDrug News.com, its affiliates, sources and/or its licensors. Any use of the Content not expressly permitted by these Terms and Conditions is a breach of these Terms and Conditions and may violate copyright, trademark, and other laws. Content is subject to change or termination without notice at the editorial discretion of RxDrug News.com

    All rights not expressly granted herein are reserved to RxDrug News.com, its content providers, and its licensors.

    All content on RxDrug News.com and affiliated web sites -- including, but not limited to, the home page, news headlines and summaries, articles, images, videos, and computer coding -- is protected by copyright either by RxDrug News.com or its contributors, licensors, partners and sponsors. No one may reproduce any of these materials, either in print or electronic form, without prior written permission from the owner(s) except as detailed below.

    If you are an editor, producer, or webmaster of a web site or blog that wishes to include RxDrug News.com's headlines and, optionally, summaries on your site, you may freely reproduce our headlines and summaries from stories with "/releases/" in the path of their URLs -- provided that you include the appropriate links to the corresponding articles on RxDrug News.com's web server and mention RxDrug News.com as the source of these links (and, optionally, any sources cited in the stories). You agree to use a functional link to the full story on the RxDrug News.com website that shall display the full content immediately (e.g., no jump pages or other intermediate or interstitial pages). You further agree not to frame or otherwise control the browser window (if any) in which our content opens, including limiting the size or position of such window. You agree not to associate any RxDrug News.com content with any content that might harm the reputation of RxDrug News.com, its affiliated sites, authors, employees, contributors or partners. Without limited the above, you may not use RxDrug News.com content on any site that displays pornographic material, exploits children, provides instruction on or promotes illegal activities, or is in any way misleading, obscene, defamatory, libelous, or invasive of personal privacy.

    Permission is also granted to place RxDrug News.com's linked headlines and summaries on your web site through the use of the RSS feed available through this link: RSS Feed. However, you are not permitted to use more content than what is provided through the RSS feed. See RSS Terms of Use for

    Please note that some of RxDrug News.com's articles are adapted from news releases issued by their respective institutions. These releases are intended for journalists and other members of the public. If you wish to quote from any part of these articles, we suggest that you credit the issuing institution as the original source of the news release, in addition to mentioning RxDrug News.com as the source of any link to the corresponding article on our server.

    Please note that Wikipedia content is governed by the GNU Free Documentation License (see the Wikipedia:Copyrights page for details). The only terms that apply to Wikipedia articles are the ones specified in the GNU Free Documentation License. Wikipedia content is identified as such on the page on which it appears.

    Use of Images
    RxDrug News.com’s policy uses both internally and externally produced images on its Sites, only with permission of the copyright holder. If you believe material to which you have rights has been improperly included, please provide the URL and a short description to info@RxDrug News.com in the subject line.

    RxDrug News.com’s images are for personal use only, not commercial use. Images and graphics (including all photos and illustrations) found on the RxDrug News.com web site should not be reused without permission of the owner of the image or copyright holder. This information is normally provided as the credit information beside each image. RxDrug News.com purchases or obtains permission for some images and graphics for use on its site, creates its own images and graphics, and obtains some from the public domain. If an image includes an identifiable person, using the image may infringe that person's right of privacy or publicity, and permission should be obtained from the person as well.

    Restrictions on Use
    User may not reverse engineer, decompile, or disassemble this Site or other products or processes accessible through this site, except and only to the extent that such activity is expressly permitted by applicable law notwithstanding this limitation.

    Limitations to Interference User agrees not to use or allow the use of any device, software or routine to interfere or attempt to interfere with the proper working of Site, not to take any action that imposes an unreasonable or disproportionately large load on the Site infrastructure, or otherwise attempt to harm the functioning or content of this site. Complete Agreement These Terms and Conditions and the RxDrug News.com Privacy Policy constitutes the entire agreement between you and RxDrug News.com and its affiliates with respect to the use of the RxDrug News.com and Content. Miscellaneous No subscription fees: Personal use of RxDrug News.com and affiliated sites is free of charge at this time. Therefore our policy is to never request credit card, password or other personal or financial information of site users. Privacy Policy Most web sites collect some sort of information about their visitors in order to gather statistics about how many visitors they get each month, what are the most and least popular pages on the web site, where there may be problems in serving certain pages to visitors, etc. In an effort to answer questions such as these, RxDrug News.com also collects certain basic information about its visitors. Please note, however, that RxDrug News.com has no interest in personally identifying its users. This would be practically quite difficult, and quite an unnecessary task to accomplish anyway. The only thing that RxDrug News.com is interested in is the overall statistics of its readership. Cumulative figures that provide a picture of visitor traffic to our site are vital in our efforts to attract advertisers--upon whose support the site depends--and to monitor how well our web server is keeping up with our ever-increasing readership. So what information does RxDrug News.com collect about its visitors? Each time someone visits the site, our web server logs a number of details--if they are available--including the IP address of the visitor's computer and/or Internet service provider, the domain name and country of origin of that computer, its operating system, and the type of web browser being used. In addition to the statistics that our own web server collects, the third-party advertising agencies that we work with may also collect certain information through the use of banner ads. Third-Party Advertising We use third-party advertising companies to serve ads when you visit our Web site. These companies may use information (not including your name, address, email address or telephone number) about your visits to this and other Web sites in order to provide advertisements on this site and other sites about goods and services that may be of interest to you. Third-Party Cookies In the course of serving advertisements to this site, our third-party advertiser may place or recognize a unique "cookie" on your browser. If you wish not to have RxDrug News.com keep any records of your visit to our site, even though it is our policy not to personally identify individual users but only to gather overall cumulative information about our visitors, then we suggest that you use an anonymous web browsing service such as Anonymizer.com. Such services typically hide all information about particular users from web sites, which log visits from the anonymizing service instead of the users' own computers. If you have any questions about our privacy policy, please contact Barry Wheeler, editor of RxDrug News.com, copyright[ @ ] RxDrug News.com. Copyright and Take-Down Procedures
    If you think that any Content accessible on RxDrug News.com or affiliated sites infringes on your copyright, you may request removal of those materials by e-mailing Barry Wheeler, RxDrug News.com's editor, at copyright[ @ ] RxDrug News.com. Please include "copyright question" in the subject line and the URL of the material, your name, address, phone number and e-mail address in the body of the message.

    If you violate any of these Terms and Conditions, your permission to use the Content automatically terminates and you must immediately destroy any copies you have made of any portion of the Content.

    Amera Davidas
    DrugNews Publishing, Inc.
    12E-2, No.141, Davidas E. MD., Lomunal District,
    Riga 105, Latvia
    Email address: copyright[ @ ] RxDrug News.com

Subscribe to the "News" RSS Feed RSS



About Us   |  Privacy Policy   |  Terms of Use   |  Contact Us  

© 2012 RxDrug News 1999-2016. All rights reserved